• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    GoodRx Holdings, Inc. - Class A Common Stock (NQ: GDRX )

    4.465 +0.025 (+0.56%)
    Streaming Delayed Price Updated: 11:49 AM EST, Dec 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 304,900
    Open 4.380
    Bid (Size) 4.460 (22)
    Ask (Size) 4.470 (21)
    Prev. Close 4.440
    Today's Range 4.370 - 4.500
    52wk Range 4.090 - 9.260
    Shares Outstanding 412,429,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
    From GoodRx Holdings, Inc.
    Via Business Wire
    GoodRx Report Shows Millions at Risk as Endocrinologist Shortages Hit Nearly 70% of U.S. Counties
    From GoodRx
    Via Business Wire

    Performance

    YTD
    -20.55%
    -20.55%
    1 Month
    -8.88%
    -8.88%
    3 Month
    -33.66%
    -33.66%
    6 Month
    -41.40%
    -41.40%
    1 Year
    -30.67%
    -30.67%

    More News

    Read More
    GoodRx Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive Officer
    From GoodRx Holdings, Inc.
    Via Business Wire
    GoodRx Holdings Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
    Via Benzinga
    Novo Nordisk's Ozempic Label Expansion Snags Approval From European Drug Regulator's Advisory Panel
    Via Benzinga
    How Much Did Americans Overspend On Weight Loss Medications in 2024? GoodRx Reveals
    Via Benzinga
    GoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still Surged
    From GoodRx
    Via Business Wire
    GOODRX ALERT: Bragar Eagel & Squire, P.C. is Investigating GoodRx Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Why GoodRx Holdings Stock Was Sinking This Week
    Via The Motley Fool
    GoodRx (GDRX) Q3 2024 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    GoodRx Reports Third Quarter 2024 Results
    From GoodRx Holdings, Inc.
    Via Business Wire
    GoodRx to Participate in Upcoming Investor Conferences
    From GoodRx Holdings, Inc.
    Via Business Wire
    GoodRx Unveils New E-commerce Platform, Launches with Opill®
    From GoodRx
    Via Business Wire
    GoodRx Announces Exclusive Low Cash Price for QSYMIA®, the Leading Branded Once-Daily Oral Weight Management Medication for Adults
    From GoodRx
    Via Business Wire
    Ronald E. Bruehlman Joins GoodRx Board of Directors
    From GoodRx
    Via Business Wire
    GoodRx Announces New Affordability Programs for Menopause Hormone Therapies
    From GoodRx
    Via Business Wire
    GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers
    From GoodRx
    Via Business Wire
    GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call
    From GoodRx Holdings, Inc.
    Via Business Wire
    GoodRx Announces Lowest Discounted Cash Price at Retail Pharmacy Locations for neffy® (epinephrine nasal spray)
    From GoodRx
    Via Business Wire
    GOODRX ALERT: Bragar Eagel & Squire, P.C. is Investigating GoodRx Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    GoodRx to Participate in Upcoming Investor Conferences
    From GoodRx Holdings, Inc.
    Via Business Wire
    GoodRx (GDRX) Q2 2024 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    GoodRx Reports Q2 Earnings With Increased Prescription Revenue But Subscription Challenges
    Via Benzinga
    GoodRx Reports Second Quarter 2024 Results
    From GoodRx Holdings, Inc.
    Via Business Wire
    MicroStrategy, Coinbase, Robinhood, Tesla And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.